ACCESSBIO CARE-START ANTIGEN TEST RCHM-02071
In Stock Shipping Daily!
Results are provided at 10 minutes. 20 Tests per Box.
This test is authorized for use at the Point of Care (POC) and users must have a CLIA Certificate of Waiver.
If you are a City, County, State, or Federal Organization. We have Government Special Pricing for you. Please give us a Call 1-877-945-2876.
Price Per Box or Kit
*Pricing Reflected in Cart
|1-31 Boxes 20 Test Kits per Box||$250 ($12.50 per Test)|
|Case Pricing 32 Boxes per Case||$200 ($10 per Test)|
|Pallet = 640 Boxes||Call for Pricing!|
Pallet Pricing on 640 + Boxes or 12,800 Tests, Please Call 1-877-945-2876 for Quote. Lowest Prices Guaranteed on Large Quantities.
(Bulk or Pallet Pricing may not be combined with any other Discounts)
Due to FDA Guidelines and Supply Chain Demands All Orders for this Product are NON-Cancellable and NON-Returnable.
By purchasing the CareStart Antigen Test from Wilburn Medical you agree to the following guidelines:
This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Below are the available bulk discount rates for each individual item when you purchase a certain amount
- Buy 32 or above and pay only $200.00 each
More Product Information
The Care-StartAntigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen in nasopharyngeal swab specimens directly collected, or collected in BD universal transport media, from individuals suspected by their healthcare provider within five days of symptom onset. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
This product has not been FDA cleared or approved, but
has been authorized by FDA under an EUA for use by
ï‚· This product has been authorized only for the detection
of proteins from SARS-CoV-2, not for any other viruses
or pathogens; and
ï‚· The emergency use of this product is only authorized for
the duration of the declaration that circumstances exist
justifying the authorization of emergency use of in vitro
diagnostics for detection and/or diagnosis of COVID-19
under Section 564(b)(1) of the Federal Food, Drug, and
Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the
declaration is terminated or authorization is revoked
PLEASE NOTE: Information above in this section might be an overall summary about the product line and not in regards to the specific product. If you have any questions, Please E-mail or Call 1-877-WILBURN (1-877-945-2876).
This product hasn't received any reviews yet. Be the first to review this product!